Your browser doesn't support javascript.
loading
Hepatectomy After Conversion Therapy for Initially Unresectable HCC: What is the Difference?
Luo, Laihui; He, Yongzhu; Zhu, Guoqing; Xiao, Yongqiang; Song, Shengjiang; Ge, Xian; Wang, Tao; Xie, Jin; Deng, Wei; Hu, Zhigao; Shan, Renfeng.
Afiliação
  • Luo L; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • He Y; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Zhu G; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Xiao Y; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Song S; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Ge X; Department of Pathology, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Wang T; Department of Day Surgery Ward, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Xie J; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Deng W; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Hu Z; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
  • Shan R; Department of General Surgery, The First Affiliated Hospital of Nanchang, Nanchang, People's Republic of China.
J Hepatocell Carcinoma ; 9: 1353-1368, 2022.
Article em En | MEDLINE | ID: mdl-36578526

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article